APA (7th ed.) Citation

R, F., & M, D. (2011). Rituximab maintenance versus radioimmunotherapy consolidation in follicular lymphoma: Which, when, and for whom? Current hematologic malignancy reports, 6(4), 207. https://doi.org/10.1007/s11899-011-0099-5

Chicago Style (17th ed.) Citation

R, Forstpointner, and Dreyling M. "Rituximab Maintenance Versus Radioimmunotherapy Consolidation in Follicular Lymphoma: Which, When, and for Whom?" Current Hematologic Malignancy Reports 6, no. 4 (2011): 207. https://doi.org/10.1007/s11899-011-0099-5.

MLA (9th ed.) Citation

R, Forstpointner, and Dreyling M. "Rituximab Maintenance Versus Radioimmunotherapy Consolidation in Follicular Lymphoma: Which, When, and for Whom?" Current Hematologic Malignancy Reports, vol. 6, no. 4, 2011, p. 207, https://doi.org/10.1007/s11899-011-0099-5.